Claeys MJ. Reperfusion injury in STEMI patients: another piece of the puzzle. Acta Cardiol. 2023; 78 (1): 162–163. doi: 10.1080/00015385.2022.2027636.
Lancellotti P, Cosyns B. Highlights of acta cardiologica. Acta Cardiol. 2022; 77 (6): 469–470. doi: 10.1080/00015385.2022.2143092.
Lancellotti P, Petitjean H, Nchimi A, et al. Special issue on ischemic heart disease. Acta Cardiol. 2023; 78 (1): 1–4. doi: 10.1080/00015385.2023.2170563.
Dahiya N, Kaur M, Singh V. Potential roles of circulatory microRNAs in the onset and progression of renal and cardiac diseases: a focussed review for clinicians. Acta Cardiol. 2023; 78 (8): 863–877. doi: 10.1080/00015385.2023.2221150.
Coban N, Erkan AF, Ozuynuk-Ertugrul AS, et al. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease. Acta Cardiol. 2023; 78 (8): 945–956. doi: 10.1080/00015385.2023.2227484.
Velibey Y, Yuksel G, Renda E, et al. Myocardial bridge in multiple coronary arteries. Acta Cardiol. 2022; 77 (1): 93–94. doi: 10.1080/00015385.2020.1867779.
Narayanan S, Joseph S, Varghese AC, et al. Plaque morphology and distribution in patients with and without myocardial bridge–an intravascular ultrasound study. Acta Cardiol. 2023; 78 (8): 894–900. doi: 10.1080/00015385.2023.2187117.
Sánchez ME, Makhoul SS, Villa-Etchegoyen C. Evaluation of coronary arteries and bicuspid aortic valve by three-dimensional transesophageal echocardiography. Acta Cardiol. 2023; 78 (8): 964–965. doi: 10.1080/00015385.2023.2240117.
Collet J-P, Thiele H. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021; 42 (20): 2020–2021. doi: 10.1093/eurheartj/ehaa909.
Van Assche L, Peeters B, Vorlat A, et al. Safety and effectiveness of the short (0-1h) high sensitive troponin protocol in real-life practice. Acta Cardiol. 2023; 78 (8): 937–944. doi: 10.1080/00015385.2023.2218028.
Vandebosch C, Dupont M, Verhaert D, et al. Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist in a patient with new-onset graves’ disease and myocarditis after SARS-CoV2-vaccination. Acta Cardiol. 2023; 78 (8): 889–893. doi: 10.1080/00015385.2022.2135224.
Kleebayoon A, Wiwanitkit V. Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist and SARS-CoV2 vaccination. Acta Cardiol. 2023; 78 (8): 974. doi: 10.1080/00015385.2023.2169438.
Özveren O, Tanalp AC, Tanboğa İH, et al. A new marker for the prediction of contrast induced-acute kidney injury following primary percutaneous coronary intervention: hemoglobin-albumin product. Acta Cardiol. 2023; 78 (8): 901–909. doi: 10.1080/00015385.2023.2187126.
Yildiz C, Yuksel Y, Efe SC, et al. Value of systemic inflammation-response index in predicting contrast-induced nephropathy in patients with ST elevation myocardial infarction. Acta Cardiol. 2023; 78 (8): 930–936. doi: 10.1080/00015385.2023.2218020.
Ma X, Mo C, Li Y, et al. Prediction of the development of contrast-induced nephropathy following percutaneous coronary artery intervention by machine learning. Acta Cardiol. 2023; 78 (8): 912–921. doi: 10.1080/00015385.2023.2198937.
Del Rio-Pertuz G, Leelaviwat N, Mekraksakit P, et al. Association between elevated CHA2DS2-VASC score and contrast-induced nephropathy among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Acta Cardiol. 2023; 78 (8): 922–929. doi: 10.1080/00015385.2023.2209406.
Choe JC, Oh J-H, Lee HC, et al. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial. Acta Cardiol. 2023; 78 (8): 880–888. doi: 10.1080/00015385.2022.2129592.
Gitmez M, Lancellotti P. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomized trial. Acta Cardiol. 2023; 78 (8): 975–976. doi: 10.1080/00015385.2023.2209441.
Jain A, Desai R, Shenwai P, et al. Impact of D-dimer levels on no-reflow phenomenon following percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. Acta Cardiol. 2023; 78 (8): 970–973. doi: 10.1080/00015385.2022.2097346.
Carolino D'Araujo S, El-Mourad M. Coronary artery compression by left ventricular pseudoaneurysm–clinical case report. Acta Cardiol. 2023; 78 (8): 959–961. doi: 10.1080/00015385.2022.2161741.
Wielgus K, Suchodolski A, Strojek M, et al. Single coronary artery with retrosternal course. Acta Cardiol. 2023; 78 (8): 962–963. doi: 10.1080/00015385.2023.2229605.
Sonsöz MR, Şişman A, Güler A. What lies behind the extensive ST–segment changes in cardiac arrest? Acta Cardiol. 2023; 78 (8): 966–967. doi: 10.1080/00015385.2023.2243062.
